Skip to main content
. 2021 Oct 4;36(1):2183–2198. doi: 10.1080/14756366.2021.1984904

Table 3.

Mean of inhibitory growth rate (%) ±SD of a pathogenic F. oxysporum with the tested compounds: All control plates have 100 ± 0 growth rate on the 8th day of cultivation.

Tested Compounds/ Control antifungal Concentration
µg/mL
Inhibition rate (%)± SD
4 days 6 days 8 days
2a 1 40.12 ± 1.70 42.13 ± 2.1 42.12 ± 4.1#
10 42.13 ± 1.03 42.01 ± 1.2 42.65 ± 1.2
50 43.55 ± 1.5 43.10 ± 1.2 44.2 ± 2.1*
3a 1 80.12 ± 1.33 80.12 ± 2.2 81.29 ± 1.9#
10 81.22 ± 1.20 82.33 ± 2.5 83.12 ± 2.5
50 83.21 ± 1.7 83.77 ± 1.2 84.0 ± 1.9 *
3b 1 79.15 ± 2.30 80.24 ± 3.1 82.34 ± 0.5#
10 80.93 ± 2.49 82.07 ± 2.5 84.13 ± 1.5
50 82.72 ± 2.8 87.77 ± 2.8 88.8 ± 2.5*
3c 1 81.25 ± 2.30 82.25 ± 7.1 83.34 ± 2.5#
10 82.83 ± 2.49 83.07 ± 1.8 85.13 ± 2.5
50 86.72 ± 2.8 87.95 ± 2.8 89.9 ± 1.5*
3d 1 70.12 ± 2.23 70.11 ± 3.1 71.12 ± 1.5#
10 71.15 ± 1.5 71.12 ± 2.1 72.14 ± 1.5
50 73.12 ± 1.5 73.00 ± 1.1 73.22 ± 1.5
4a 1 72.12 ± 1.62 72.21 ± 3.2 72.10 ± 2.4#
10 72.16 ± 2.31 72.21 ± 1.4 72.33 ± 2.5
50 73.13 ± 2.5 73.12 ± 3.0 73.0 ± 1.0
4d 1 65.35 ± 1.5 73.0.5 ± 1.09 78.37 ± 2.1#
10 71.21 ± 1.5 74.153 ± 1.09 78.5 ± 0.33
50 76.95 ± 2.1 78.17 ± 1.08 80.12 ± 0.5*
5a 1 85.12 ± 3.20 86.52 ± 2.1 88.21 ± 0.4
10 87.52 ± 2.5 87.90 ± 2.5 88.12 ± 1.6
50 88.30 ± 1.5 88.10 ± 1.2 88.22 ± 7.0*
5b 1 81.15 ± 6.30 82.24 ± 7.1 83.34 ± 2.4#
10 81.93 ± 2.49 82.07 ± 1.8 84.13 ± 2.5
50 87.72 ± 2.8 87.77 ± 2.8 88.8 ± 2.5*
5c 1 34.21 ± 2.47 35.00 ± 2.12 36.52 ± 3.24#
10 34.76 ± 1.3 35.13 ± 2.3 35.7 ± 1.77
50 36.89 ± 1.26 37.17 ± 1.04 38.22 ± 1.5*
5d 1 71.15 ± 2.22 72.25 ± 2.2 74.37 ± 1.45#
10 72.12 ± 2.1 73.53 ± 1.24 75.9 ± 2.33
50 73.12 ± 2.11 74.22 ± 2.15 76.12 ± 2.5
6a 1 66.21 ± 1.2 72.0.5 ± 1.09 77.37 ± 2.1#
10 70.1.08 ± 0.5 73.153 ± 1.09 77.5 ± 0.33
50 75.89 ± 2.1 77.17 ± 1.08 79.12 ± 0.5*
6b 1 80.13 ± 2.30 81.20 ± 2.5 82.31 ± 2.0#
10 81.23 ± 2.43 82.50 ± 1.8 84.15 ± 1.5
50 85.72 ± 2.8 85.77 ± 2.8 88.8 ± 1.5*
6c 1 40.95 ± 1.0 40.22 ± 1.1 41.09 ± 1.5#
10 41.21 ± 1.2 41.40 ± 2.3 42.12 ± 1.5
50 42.32 ± 2.1 43.02 ± 2.2 44.0 ± 2.1*
6d 1 72.13 ± 1.55 72.33 ± 1.5 73.55 ± 1.5#
10 73.11 ± 2.14 73.26 ± 1.7 74.12 ± 4.5
50 74.19 ± 2.4 74.99 ± 7.3 75.2 ± 2.5
6e 1 80.15 ± 4.30 81.24 ± 7.1 82.34 ± 2.4#
10 81.93 ± 2.49 81.07 ± 1.8 83.13 ± 1.5
50 85.22 ± 2.5 85.72 ± 2.8 86.8 ± 2.5*
Kocide 2000 2500 64.5 ± 1.5 65.2 ± 0.4 70.5 ± 0.5
Itraconazole 6.25 82.0 ± 1.5 89.0 ± 0.6 93.5 ± 0.5

Data shown in Table 3 are expressed as mean ± SD (Standard deviation);.

*Significant difference from positive control (Kocide 2000 compared to concentration of 50 µg/mL of the tested compounds) at p < 0.05.

#Significant difference from positive control (Itraconazole compared to concentration of 1 µg/mL of the tested compounds) at p < 0.05.